Form 8-K - Current report:
SEC Accession No. 0000950103-25-003637
Filing Date
2025-03-19
Accepted
2025-03-19 16:22:25
Documents
15
Period of Report
2025-03-19
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp226512_8k.htm   iXBRL 8-K 23372
2 EXHIBIT 99.1 dp226512_ex9901.htm EX-99.1 70859
3 GRAPHIC image_002.jpg GRAPHIC 1803
  Complete submission text file 0000950103-25-003637.txt   279938

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE pgen-20250319.xsd EX-101.SCH 3015
5 XBRL LABEL FILE pgen-20250319_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE pgen-20250319_pre.xml EX-101.PRE 22359
17 EXTRACTED XBRL INSTANCE DOCUMENT dp226512_8k_htm.xml XML 3551
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Filer) CIK: 0001356090 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36042 | Film No.: 25753036
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)